Validation of ion mobility spectrometry - mass spectrometry as a screening tool to identify type II kinase inhibitors of FGFR1 kinase.

Beeston, Helen S; Klein, Tobias; Norman, Richard A; Tucker, Julie A; Anderson, Malcolm; Ashcroft, Alison E; Holdgate, Geoffrey A

Beeston, Helen S; Klein, Tobias; Norman, Richard A; Tucker, Julie A; Anderson, Malcolm; Ashcroft, Alison E; Holdgate, Geoffrey A.

Afiliação

Beeston HS; Astbury Centre for Structural Molecular Biology & Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.
Klein T; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, UK.
Norman RA; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, UK.
Tucker JA; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, UK.
Anderson M; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, UK.
Ashcroft AE; Astbury Centre for Structural Molecular Biology & Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.
Holdgate GA; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, UK.

Rapid Commun Mass Spectrom ; : e9130, 2021 May 26.

Article em En | MEDLINE | ID: mdl-34038603

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article